These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3805210)

  • 21. Reversed-phase high-performance liquid chromatography of phenylbutazone in body fluids.
    Alvinerie M
    J Chromatogr; 1980 Jan; 181(1):132-4. PubMed ID: 7364907
    [No Abstract]   [Full Text] [Related]  

  • 22. Gas-liquid chromatography of hydroxamic acids in biological samples. Detection and quantitation of Bufexamac and one of its major metabolites in plasma and urine.
    Roncucci R; Simon MJ; Lambelin G
    J Chromatogr; 1971 May; 57(3):410-2. PubMed ID: 5091949
    [No Abstract]   [Full Text] [Related]  

  • 23. Disposition of [4-14C]mofebutazone in the rat.
    Bass VM; Mrongovius RI; Schulte KE
    Eur J Drug Metab Pharmacokinet; 1980; 5(4):201-6. PubMed ID: 7250143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of mofebutazone in comparison to phenylbutazone on the adenosine triphosphate level of polymorphonuclear cells and their migration.
    Partsch G
    Arzneimittelforschung; 1992 Nov; 42(11):1336-8. PubMed ID: 1492846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of 6,11-dihydro-11-oxo-dibenz[b,e] oxepin-2-acetic acid (isoxepac) in plasma and urine by gas--liquid chromatography.
    Bryce TA; Burrows JL
    J Chromatogr; 1978 May; 145(3):393-400. PubMed ID: 659525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GLC determination of plasma concentrations of gamma-oxo metabolite of phenylbutazone.
    Midha KK; McGilveray IJ; Cooper JK
    J Pharm Sci; 1978 Feb; 67(2):279-81. PubMed ID: 621659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of kebuzone to human serum albumin studied by high performance liquid affinity chromatography.
    Zhivkova ZD; Russeva VN
    Arzneimittelforschung; 2000 Mar; 50(3):272-5. PubMed ID: 10758780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case study of illicit preparation of antirheumatic analgesic with phenylbutazone as active ingredient.
    Thuan CE; Huat LB
    Med J Malaysia; 1989 Jun; 44(2):160-6. PubMed ID: 2626126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
    Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
    Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Various clinical and biohumoral effects of pyrasanone in rheumatoid arthritis].
    Glorioso S; Punzi L; Todesco S
    Clin Ter; 1976 Dec; 79(5):419-33. PubMed ID: 798649
    [No Abstract]   [Full Text] [Related]  

  • 31. Gas chromatographic assay of phenylbutazone in biological fluids.
    Perego R; Martinelli E; Vanoni PC
    J Chromatogr; 1971 Jan; 54(2):280-1. PubMed ID: 5545786
    [No Abstract]   [Full Text] [Related]  

  • 32. [New method of determination of phenylbutazone in the urine and blood].
    Pomazańska-Kołodziejska T
    Acta Pol Pharm; 1980; 37(4):447-50. PubMed ID: 7446182
    [No Abstract]   [Full Text] [Related]  

  • 33. Ultraviolet spectrophotometric determination of phenylbutazone in biologic specimens.
    Wallace JE
    J Pharm Sci; 1968 Dec; 57(12):2053-6. PubMed ID: 5708342
    [No Abstract]   [Full Text] [Related]  

  • 34. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control of phenylbutazone II: Analysis of phenylbutazone and its decomposition products in drugs by high-pressure liquid chromatography.
    Fabre H; Mandrou B; Eddine H
    J Pharm Sci; 1982 Jan; 71(1):120-2. PubMed ID: 7057365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of fluticasone propionate in horse plasma and urine following inhaled administration.
    Gray BP; Biddle S; Pearce CM; Hillyer L
    Drug Test Anal; 2013 May; 5(5):306-14. PubMed ID: 22514113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of flunisolide and its principal hydrolytic metabolite in urine and plasma by LC-NICI-MS with a particle beam interface].
    Rauli S; Del Puppo M; De Angelis L; Galli Kienle M
    Boll Chim Farm; 1997 Apr; 136(4):308-15. PubMed ID: 9312218
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of six non-steroidal anti-inflammatory agents in plasma and urine by HPLC [proceedings].
    Thomas WO; Jefferies TM; Parfitt RT
    J Pharm Pharmacol; 1978 Dec; 30 Suppl():66P. PubMed ID: 32324
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of plasma and urine levels of a new anti-inflammatory agent, 4,5-bis-(4-methoxyphenyl)-2-(2-hydroxymethylsulfinyl)-imidazole, by high-performance liquid chromatography and electrochemical or ultraviolet detection.
    Krause W
    J Chromatogr; 1981 Jan; 222(1):71-9. PubMed ID: 7217328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mofebutazone--mechanism of action, pharmacokinetics, tolerance].
    Fortschr Med Suppl; 1992; 123():3-13. PubMed ID: 1547984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.